Neuroendocrine liver metastasis treated by using intraarterial therapy: volumetric functional imaging biomarkers of early tumor response and survival.

@article{Halappa2013NeuroendocrineLM,
  title={Neuroendocrine liver metastasis treated by using intraarterial therapy: volumetric functional imaging biomarkers of early tumor response and survival.},
  author={Vivek Gowdra Halappa and Celia P. Corona-Villalobos and Susanne Bonekamp and Zhen Li and Diane K. Reyes and David Peter Cosgrove and Timothy M Pawlik and Luis A Diaz and N. S. Bhagat and John Eng and Jean Francois H Geschwind and Ihab R. Kamel},
  journal={Radiology},
  year={2013},
  volume={266 2},
  pages={502-13}
}
PURPOSE To determine if volumetric changes of diffusion-weighted and contrast material-enhanced magnetic resonance (MR) imaging can help assess early tumor response to intraarterial therapy (IAT) in neuroendocrine liver metastasis (NELM). MATERIALS AND METHODS This retrospective single-center comprehensive imaging analysis was performed in compliance with HIPAA and was institutional review board approved. Informed patient consent was waived. Seventy-one patients (39 men; mean age, 62.3 years… CONTINUE READING

9 Figures & Tables

Connections & Topics

Mentioned Connections BETA
To determine if volumetric changes of diffusion - weighted and contrast material - enhanced magnetic resonance ( MR ) imaging can help assess early tumor response to intraarterial therapy ( IAT ) in neuroendocrine liver metastasis ( NELM ) .
Neuroendocrine liver metastasis treated by using intraarterial therapy : volumetric functional imaging biomarkers of early tumor response and survival .
All Topics